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Association between post-hospital clinic
and telephone follow-up provider visits
with 30-day readmission risk in an
integrated health system
Huong Q. Nguyen1*, Aileen Baecker1, Timothy Ho2, Dan N. Huynh2, Heather L. Watson2, Jing Li3 and Ernest Shen1

Abstract
Background: Follow-up visits with clinic providers after hospital discharge may not be feasible for some patients
due to functional limitations, transportation challenges, need for physical distancing, or fear of exposure especially
during the current COVID-19 pandemic.
Methods: The aim of the study was to determine the effects of post-hospital clinic (POSH) and telephone (TPOSH)
follow-up provider visits versus no visit on 30-day readmission. We used a retrospective cohort design based on
data from 1/1/2017 to 12/31/2019 on adult patients (n = 213,513) discharged home from 15 Kaiser Permanente
Southern California hospitals. Completion of POSH or TPOSH provider visits within 7 days of discharge was the
exposure and all-cause 30-day inpatient and observation stay readmission was the primary outcome. We used
matching weights to balance the groups and Fine-Gray subdistribution hazard model to assess for readmission risk.
Results: Unweighted all-cause 30-day readmission rate was highest for patients who completed a TPOSH (17.3%)
followed by no visit (14.2%), non-POSH (evaluation and management visits that were not focused on the
hospitalization: 13.6%) and POSH (12.6%) visits. The matching weighted models showed that the effects of POSH
and TPOSH visits varied across patient subgroups. For high risk (LACE 11+) medicine patients, both POSH (HR: 0.77,
95% CI: 0.71, 0.85, P < .001) and TPOSH (HR: 0.91, 95% CI: 0.83, 0.99, P = .03) were associated with 23 and 9% lower
risk of 30-day readmission, respectively, compared to no visit. For medium to low risk medicine patients (LACE< 11)
and all surgical patients regardless of LACE score or age, there were no significant associations for either visit type
with risk of 30-day readmission.
Conclusions: Post-hospital telephone follow-up provider visits had only modest effects on 30-day readmission in
high-risk medicine patients compared to clinic visits. It remains to be determined if greater use and comfort with
virtual visits by providers and patients as a result of the pandemic might improve the effectiveness of these
encounters.
Keywords: Care transition, Readmission, Post-discharge provider follow-up
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Introduction
Transitional care management after hospital discharge
typically includes a follow-up provider clinic visit within
7–14 days depending on patient complexity [1, 2]. We
previously reported on the association between completion of a dedicated post-hospital (POSH) follow-up provider clinic visit with a 24% lower risk of 30-day
inpatient readmissions in older patients within an integrated health system [3], a finding similar to other studies [4–6]. Nonetheless, since clinic visits were
challenging for high risk patients who have functional
limitations or no transportation, the health system began
offering telephone POSH (TPOSH) appointments as an
alternative to the clinic visits in 2015. Uptake of the
TPOSH was limited and comprised only 7% of the postdischarge follow-up encounters prior to the COVID-19
pandemic.
In response to the dramatic shift to greater use of telehealth for routine clinic appointments out of necessity
due to the COVID-19 pandemic [7], we aimed to advance the care transition evidence base by using data
prior to the public health emergency to examine the effects of clinic (POSH) and telephone (TPOSH) visits
completed within 7 days of discharge with a provider on
30-day inpatient and observation stay readmission compared to no visit and whether these effects varied by age,
service line (medicine or surgical) and readmission risk
as secondary analyses. In contrast to our earlier report
[3], the analyses herein leverage a more contemporary
cohort that reflects secular changes in transitional care
management practices since 2014, is not restricted to
older adults, and is not adversely affected by the disruptions in healthcare due to the COVID-19 pandemic.
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scheduled before hospital discharge with all sites consistently achieving > 85% appointments scheduled for high
risk patients. TPOSH visits may be offered by hospital
scheduling staff to patients who they anticipated would
have challenges with completing a clinic POSH visit or
were offered by call center staff if patients reported that
they could not attend their POSH clinic appointment.
POSH/TPOSH visits were flagged for the provider as being a post-hospital follow-up visit in the electronic medical record (EMR); reminders for routine care issues
were suppressed during these visits. Providers were
trained to focus on the post-discharge summary, medication review and issues that required follow-up. The
POSH and TPOSH visits were generally 20 min in
length. Other than the inability to conduct a physical assessment during a TPOSH, providers were expected to
address standard transitional care needs of the patient.
The TPOSH/POSH may take place before or after a
standard 48–72-h post-discharge telephone call by an allied health staff. A non-POSH visit could have been
scheduled before or after the hospitalization by the patient or a provider (primary care, specialist, and other
clinicians) for any reason, including evaluation and management; the focus of these visits was not specifically on
the hospitalization. Patients may have a follow-up visit
with specialty care as a result of the hospitalization but
due to challenges with access, these visits may not occur
within the first 7 days of discharge.
Covariates

This retrospective cohort study included the first
hospitalization for all adult patients who were discharged
alive from 15 Kaiser Permanente Southern California
(KPSC) hospitals between January 1, 2017 to December
31, 2019 to home or home health and remained enrolled
in the health plan for at least 30 days post-discharge.
This study was approved by the KPSC Institutional Review Board.

Socio-demographic (age, gender, race/ethnicity, being
partnered), behavioral (no-show history in the last 12
months), social risk (receipt of medical financial assistance from the health plan in the year prior to admission), and clinical characteristics [risk for readmission or
early death score based on length of stay, age, comorbidities, and emergency department visits in the prior 6
months (LACE category [8]), severity of the index
hospitalization (LAPS2) [9], discharge disposition (home
vs. home health), service line (medicine vs. surgical),
functional status (non-ambulatory vs. ambulatory), falls
risk (Schmid [10] score of 3+) within 24 h of discharge,
and frailty category [11]] were obtained or calculated
from the electronic medical record (EMR) system.

Transitional care management

Outcome

Continuous performance improvement efforts across the
15 hospitals focused on ensuring that follow-up provider
visits were scheduled within 7 days of discharge for
medicine high risk patients as determined by a LACE
score [8] of 11 or higher during this study period; hospitals with greater resources were encouraged to also
schedule appointments for medium risk (LACE score 7–
10) patients. Most POSH and TPOSH visits were

The primary outcome was all-cause 30-day inpatient or
observation stay readmission obtained from the EMR
and claims.

Methods
Study design and sample

Statistical analysis

Although the rate of death in the overall sample was low
(1.5%), the higher rate among the TPOSH group (3.6%)
indicated a need to account for death as a competing
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risk, using the subdistribution hazard approach of Fine
and Gray [12]. We treated visit completion as a timedependent variable that could change in the first 7
days. While using time-varying covariates (i.e. visit
completion) with the Fine-Gray subdistribution hazard
model can preclude the estimation of their effect on
either the subdistribution hazard or cumulative incidence function, visit completion as we defined it is
fixed for all subsequent risk sets, and so is not subject to this limitation [13].
We used matching weights [14] where the propensity
score (PS) were calculated using generalized boosted
models [15, 16] to address confounding instead of regression adjustment, inverse probability of treatment
weights (IPTW) or matching approaches. We chose to
use matching weights for several reasons: 1) it provides
the average treatment effect on the treated (ATT) interpretation of switching patients from one exposure group
to another (unlike IPTW which estimates average treatment effects on the entire sample); 2) it mitigates the
bias that results from using IPTW when some groups
have extreme weights such as we observed for the
TPOSH group, in which case the substantial nonoverlap on the PS [17] results in a violation of the common support assumption, by effectively assigning those
with an extreme PS a weight close to 1; and 3) it avoids
the nuances and complexity of matching on three or
more groups to estimate the ATT, while also precluding
the need to either exclude some patients from a matched
analysis or introduce additional complexity by doing full
matching [14, 18].
Covariates that were meaningfully associated with either visit completion or readmission [age, gender, race/
ethnicity, being partnered, no-show history in the last
12 months, receipt of medical financial assistance in the
year prior to admission (a marker of social risk), risk for
readmission or early death (LACE category [8]), severity
of hospitalization (LAPS2) [9], discharge disposition
(home vs. home health), service line (medicine vs. surgical), functional status (non-ambulatory vs. ambulatory)
and fall risk (Schmid [10] score of 3+) within 24 h of discharge, frailty category [11], and hospital site] were included in the multinomial regression models to estimate
propensity scores to construct the matching weights.
Such associations were deemed meaningful using a combination of prior literature and examining statistical
measures of association (namely the maximum standardized pairwise differences). Secondary subgroup analyses
were stratified by age (< 65 or 65+), service line (medicine vs. surgical) and LACE score (< 11: medium to low
risk vs. 11+: high risk), to assess for heterogeneity of
treatments effects. Analyses were performed with SAS
Enterprise Guide 7.1 (Cary, North Carolina). A P < .05
was considered significant.
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Results
Patient flow

The initial cohort of 390,365 adult, non-maternity patients discharged alive from 15 hospitals was pared down
to a total of 213,513 unique patients who had their first
index hospitalization during the study period after excluding 71,526 patients due to discharge disposition elsewhere not to home or home health, 9115 patients not
enrolled for at least 30 days post discharge, and 96,211
patients with repeat hospitalizations during the study
period (Fig. 1).
Sample characteristics

Approximately 30% of patients completed a POSH (26%)
or TPOSH (4%) visit within 7-days of hospital discharge;
33% had a non-POSH visit and 37% did not have any
clinic visit (Tables 1 and 2). Approximately 57% of the
high-risk medicine LACE patients for whom the hospitals prioritized for scheduling follow-up appointments
completed a POSH or TPOSH visit within 7 days
whereas 25% of the medium to low-risk medicine LACE
patients completed such visits. Patients who completed a
TPOSH tended to be older, had higher co-morbidities,
frailty and readmission risk compared to patients completing other visit types or no visit. Surgical patients
were more likely to complete nonPOSH visits or no visit
compared to medicine patients. The maximum standardized differences in matching weights across all
baseline variables were all < 0.10 indicating acceptable
balance across all six possible pairwise comparisons
(POSH vs. no visit, TPOSH vs. no visit, nonPOSH vs. no
visit, POSH vs. TPOSH, POSH vs. nonPOSH, TPOSH
vs. nonPOSH) [19].
A total of 29,288 (13.7%) and 3115 (1.5%) of patients
were readmitted or died within 30 days of being discharged alive, respectively. Among those patients who
died within 30 days, 58% had a readmission prior to
death, while the remainder had a median survival time
of 13 days (IQR: 6, 21). The unweighted all-cause 30-day
readmission rate was highest for patients who completed
a TPOSH (17.3%) followed by no visit (14.2%), nonPOSH (13.6%) and POSH (12.6%) (Table 2).
Overall primary analyses

For all patients, only POSH (HR: 0.83, 95% CI: 0.77,
0.90, P < .001) provider visits completed within 7 days of
hospital discharge were associated with a 17% lower risk
of 30-day inpatient or observation readmission compared to no visit in the weighted models (Table 3).
TPOSH provider visits were not associated with reductions in readmission risk for all patients (HR: 0.97, 95%
CI: 0.90, 1.05, P = .48). POSH provider visits were associated with 15% lower risk of 30-day readmission
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Fig. 1 Sample Flow

compared to TPOSH provider visits (HR: 0.85, 95% CI:
0.79, 0.93, P < .01).
Secondary subgroup analyses

For high risk (LACE 11+) medicine patients, both POSH
(HR: 0.77, 95% CI: 0.71, 0.85, P < .001) and TPOSH (HR:
0.91, 95% CI: 0.83, 0.99, P = .03) provider visits were associated with 23 and 9% lower risk of 30-day readmission, respectively, compared to no visit in the weighted
models. For medium to low risk patients (LACE< 11),
neither POSH (HR: 0.84, 95% CI: 0.67, 1.05, P = .12) nor
TPOSH (HR: 1.14, 95%CI: 0.94, 1.39, P = 0.19) provider
visits were associated with lower readmission risk compared to no visit.
For all surgical patients regardless of LACE score or
age, there were no significant associations for any visit
type with risk of 30-day readmission in the weighted
models.

Discussion
Using a more contemporary and diverse cohort of patients discharged from hospital to home or home health,
we found that completion of either a clinic or telephone
provider follow-up visit within 7 days of discharge was
associated with lower 30-day readmission compared to
no visit only for high risk medicine patients. The risk reduction for POSH provider visits was comparable to our
previous report [3] while the TPOSH effects though statistically significant, were marginal at best. A surprising
finding was that none of the visit types were associated

with lower readmission for lower risk medicine and all
surgical patients.
Although the TPOSH was introduced to address a gap
for patients who have mobility and transportation challenges and who would otherwise not have any follow-up
provider visit, the limited effects of TPOSH compared to
POSH were not surprising for several reasons. Clinic
providers may have had insufficient practice with telephonic transitional care management prior to the pandemic as demonstrated in the small volume of TPOSH
visits and may have been more cautious in directing patients to seek hospital-based care for worsening symptoms. Other ancillary team members were not able to
augment the provider’s care as they would during a
clinic visit. Neither physical exams nor visual assessments were performed during these encounters and thus
providers were limited to patient and/or family selfreport. With as many as half of elderly hospitalized patients having cognitive impairment [20], and possibly,
without the assistance of a capable family member, gaps
in communication and early detection of decompensation may be problematic. Use of video and/or remote assessments or biometrics could potentially enhance the
effectiveness of these telephone encounters, especially
for more complex, higher-risk older patients but only if
family can assist with these technologies [21, 22].
The COVID-19 pandemic has accelerated adoption of
digital technologies [7, 23] across all aspects of health
care, especially with physically-distanced care and the
earlier discharge of COVID-19 patients to increase hospital capacity [24]. Learnings from use of digital home-
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Table 1 Baseline sample characteristics by completion of post-hospital follow-up provider visits within 7-days of discharge
POSH

TPOSH

Non-POSH

No Visit

Total

Max Std Diff

n = 56,383
(26.4%)

n = 9009
(4.2%)

n = 69,997
(32.8%)

n = 78,124
(36.6%)

n = 213,513

Not
Wgtd

Wgtd

Age

66.5 (16.4)

69.5 (16.2)

58.9 (17.8)

57.8 (18.6)

60.9 (18.1)

0.68

0.05

Female

27,203 (48.2%)

4857 (53.9%)

36,903 (52.7%)

45,197 (57.9%)

114,160 (53.5%)

0.10

0.01

Asian

5042 (8.9%)

721 (8%)

6432 (9.2%)

6459 (8.3%)

18,654 (8.7%)

0.01

0.00

Black

6440 (11.4%)

1446 (16.1%)

7434 (10.6%)

9146 (11.7%)

24,466 (11.5%)

0.05

0.01

Hispanic

18,788 (33.3%)

2517 (27.9%)

24,815 (35.5%)

28,760 (36.8%)

74,880 (35.1%)

0.09

0.01

Other

1041 (1.8%)

155 (1.7%)

1385 (2%)

1554 (2%)

4135 (1.9%)

0.00

0.00

White

25,072 (44.5%)

4170 (46.3%)

29,931 (42.8%)

32,205 (41.2%)

91,378 (42.8%)

0.05

0.01

Socio-demographics

Race/Ethnicity

Marital status: Partnered

32,842 (58.2%)

4622 (51.3%)

42,151 (60.2%)

44,166 (56.5%)

123,781 (58%)

0.09

0.01

Education: < College

41,216 (73.1%)

6504 (72.2%)

50,048 (71.5%)

56,640 (72.5%)

154,370 (72.3%)

0.09

0.05

Household income: >$20,000

48,602 (86.2%)

7667 (85.1%)

60,477 (86.4%)

67,187 (86.0%)

184,048 (86.2%)

0.15

0.06

Spoken language: English

48,993 (86.9%)

8108 (90%)

62,222 (88.9%)

69,453 (88.9%)

188,776 (88.4%)

0.03

0.02

Insurance typea
Commercial/private pay

21,503 (38.1%)

2772 (30.8%)

37,651 (53.8%)

43,070 (55.1%)

104,996 (49.2%)

0.24

0.02

Dual

3215 (5.7%)

591 (6.6%)

2450 (3.5%)

2907 (3.7%)

9163 (4.3%)

0.03

0.01

Medicaid

2493 (4.4%)

392 (4.4%)

3838 (5.5%)

4754 (6.1%)

11,477 (5.4%)

0.02

0.01

Medicare

29,160 (51.7%)

5250 (58.3%)

26,035 (37.2%)

27,330 (35%)

87,775 (41.1%)

0.23

0.02

4590 (8.1%)

941 (10.4%)

5163 (7.4%)

5035 (6.4%)

15,729 (7.4%)

0.04

0.00

34,084 (60.5%)

6185 (68.7%)

43,594 (62.3%)

47,297 (60.5%)

131,160 (61.4%)

0.08

0.01

Received medical financial assistance in prior year
Health and Behavior Before Hospitalization
Clinic no show rate (at least once)
b

4.7 (3.08)

5.5 (3.14)

3.8 (2.99)

3.4 (2.94)

4.0 (3.07)

0.68

0.03

Myocardial infarction

9635 (17.1%)

1727 (19.2%)

7030 (10%)

6703 (8.6%)

25,095 (11.8%)

–

–

Congestive heart failure

13,396 (23.8%)

2684 (29.8%)

9295 (13.3%)

8613 (11%)

33,988 (15.9%)

–

–

Peripheral vascular disease

26,973 (47.8%)

5236 (58.1%)

22,050 (31.5%)

22,215 (28.4%)

76,474 (35.8%)

–

–

Charlson comorbidity index

Cerebrovascular disease

12,175 (21.6%)

2358 (26.2%)

9105 (13%)

9833 (12.6%)

33,471 (15.7%)

–

–

Dementia

3536 (6.3%)

1134 (12.6%)

1940 (2.8%)

3357 (4.3%)

9967 (4.7%)

–

–

Rheumatic disease

3937 (7%)

710 (7.9%)

3692 (5.3%)

3711 (4.8%)

12,050 (5.6%)

–

–

Peptic ulcer disease

3779 (6.7%)

687 (7.6%)

3094 (4.4%)

3296 (4.2%)

10,856 (5.1%)

–

–

Mild liver disease

8727 (15.5%)

1499 (16.6%)

9095 (13%)

9301 (11.9%)

28,622 (13.4%)

–

–

Moderate or severe liver disease

1355 (2.4%)

236 (2.6%)

890 (1.3%)

837 (1.1%)

3318 (1.6%)

–

–

Diabetes without chronic complication

7821 (13.9%)

1159 (12.9%)

8766 (12.5%)

9464 (12.1%)

27,210 (12.7%)

–

–

Diabetes with chronic complication

18,284 (32.4%)

3201 (35.5%)

14,142 (20.2%)

12,878 (16.5%)

48,505 (22.7%)

–

–

Hemiplegia or paraplegia

2909 (5.2%)

740 (8.2%)

2211 (3.2%)

2721 (3.5%)

8581 (4%)

–

–

Renal disease

20,089 (35.6%)

3776 (41.9%)

14,696 (21%)

14,609 (18.7%)

53,170 (24.9%)

–

–

Any malignancy (lymphomas, leukemias etc)

8825 (15.7%)

1788 (19.8%)

11,963 (17.1%)

9563 (12.2%)

32,139 (15.1%)

–

–

Metastatic solid tumor

3343 (5.9%)

830 (9.2%)

4578 (6.5%)

3006 (3.8%)

11,757 (5.5%)

–

–

236 (0.4%)

51 (0.6%)

281 (0.4%)

244 (0.3%)

812 (0.4%)

–

–

8.8 (6.65)

11.1 (8.35)

6.1 (6.05)

5.7 (6.44)

6.9 (6.65)

AIDS/HIV
Frailty index
Low risk < 5

18,052 (32%)

2310 (25.6%)

37,893 (54.1%)

46,855 (60%)

105,110 (49.2%)

0.34

0.01

Intermediate risk 5–14

29,643 (52.6%)

4366 (48.5%)

26,225 (37.5%)

24,610 (31.5%)

84,844 (39.7%)

0.21

0.01

High Risk 15+

8688 (15.4%)

2333 (25.9%)

5879 (8.4%)

6659 (8.5%)

23,559 (11%)

0.17

0.01

Values are presented as either mean (SD) or n (column %), unless otherwise indicated
POSH Post-hospital follow-up clinic visit, TPOSH Post-hospital follow-up telephone visit, nonPOSH visit not related to post-hospital follow-up
Wgtd Weighted maximum standardized differences across groups
a
Missingness < 0.1
b
Weighting only done on index, not individual conditions
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Table 2 Characteristics of the index hospitalization, 30-day readmission and mortality
POSH

TPOSH

Non-POSH

No Visit

Total

Max Std Diff

n = 56,383
(26.4%)

n = 9009
(4.2%)

n = 69,997
(32.8%)

n = 78,124
(36.6%)

n = 213,513

Not
Wgtd
Wgtd

All cause 30-day inpatient or observation
stay readmission

7093 (12.6%)

1562 (17.3%) 9540 (13.6%)

11,093 (14.2%) 29,288 (13.7%)

–

–

30-day mortality

605 (1.1%)

324 (3.6%)

683 (1.0%)

1503 (1.9%)

–

–

60,593 (86.6%) 68,386 (87.5%) 182,485 (85.5%) 0.09

3115 (1.5%)

Index Hospitalization
Source of admissiona
Home/clinic

46,209 (82%)

7297 (81%)

Hospital/SNF

9912 (17.6%)

1628 (18.1%) 8748 (12.5%)

9157 (11.7%)

29,445 (13.8%)

0.06

0.03

Other

204 (0.4%)

45 (0.5%)

493 (0.6%)

1350 (0.6%)

0.01

0.00

Surgical

9775 (17.3%)

1773 (19.7%) 40,411 (57.7%) 48,886 (62.6%) 100,845 (47.2%) 0.45

Medicine

46,608 (82.7%) 7236 (80.3%) 29,586 (42.3%) 29,238 (37.4%) 112,668 (52.8%) –

–

11,626 (37.6%) 1623 (5.2%)

0.05

608 (0.9%)

0.02

Service line
0.03

Major diagnostic categories (row %)
Diseases/Disorders of the Circulatory System

Diseases/Disorders of the Musculoskeletal System 2421 (8.5%)

696 (2.5%)

10,512 (34%)

7173 (23.2%)

30,934 (14.5%)

0.11

9188 (32.4%)

16,049 (56.6%) 28,354 (13.3%)

0.16

0.05

Infectious & Parasitic Diseases, Systemic or
Unspecified Sites

11,584 (42.4%) 1845 (6.7%)

6574 (24%)

7343 (26.9%)

27,346 (12.8%)

0.11

0.04

Diseases/Disorders of the Digestive System

6672 (27.5%)

977 (4%)

7443 (30.7%)

9187 (37.8%)

24,279 (11.4%)

0.01

0.02

Diseases/Disorders of the Nervous System

4946 (33.2%)

595 (4%)

4431 (29.7%)

4940 (33.1%)

14,912 (7%)

0.02

0.03

Endocrine, Nutritional & Metabolic Diseases &
Disorders

1922 (15.4%)

362 (2.9%)

3528 (28.3%)

6635 (53.3%)

12,447 (5.8%)

0.05

0.01

Diseases/Disorders of the Respiratory System

4985 (40.7%)

822 (6.7%)

3111 (25.4%)

3317 (27.1%)

12,235 (5.7%)

0.05

0.02

Diseases/Disorders of the Hepatobiliary System

3212 (27.4%)

420 (3.6%)

3373 (28.7%)

4739 (40.4%)

11,744 (5.5%)

0.01

0.01

Laboratory Acute Physiology Score (LAPS2)

70.1 (30.42)

73.4 (31.94)

57.8 (27.98)

56.2 (28.43)

61.1 (29.66)

0.58

0.03

LACE readmission risk score

10.4 (2.80)

11.2 (2.93)

8.0 (3.59)

7.0 (3.66)

8.4 (3.70)

LACE < 11

26,301 (46.6%) 2810 (31.2%) 52,055 (74.4%) 64,181 (82.2%) 145,347 (68.1%) 0.51

0.02

LACE 11 to 15

28,897 (51.3%) 5787 (64.2%) 16,928 (24.2%) 12,997 (16.6%) 64,609 (30.3%)

0.48

0.04

LACE 16 to 19

1185 (2.1%)

0.03

0.01

412 (4.6%)

1014 (1.4%)

946 (1.2%)

3557 (1.7%)

Length of stay
0–3 days

29,460 (52.2%) 4044 (44.9%) 44,692 (63.8%) 57,202 (73.2%) 135,398 (63.4%) 0.28

0.05

4–6 days

17,659 (31.3%) 2998 (33.3%) 16,312 (23.3%) 14,789 (18.9%) 51,758 (24.2%)

0.04

0.14

7–13 days

7491 (13.3%)

1427 (15.8%) 7221 (10.3%)

4913 (6.3%)

21,052 (9.9%)

0.10

0.02

14+ days

1773 (3.1%)

540 (6%)

1220 (1.6%)

5305 (2.5%)

0.04

0.02

Non-ambulatory

6177 (11%)

2231 (24.8%) 7213 (10.3%)

11,525 (14.8%) 27,146 (12.7%)

0.14

0.01

Ambulatory with assistance

27,514 (48.8%) 4057 (45%)

27,458 (39.2%) 29,276 (37.5%) 88,305 (41.4%)

0.11

0.00

Ambulatory

21,965 (39%)

2569 (28.5%) 28,967 (41.4%) 30,000 (38.4%) 83,501 (39.1%)

0.13

0.01

1772 (2.5%)

Functional status within 24 h of discharge

Missing
Schmid fall risk score 3+ within 24 h of discharge

727 (1.3%)

152 (1.7%)

9354 (16.6%)

2107 (23.4%) 11,882 (17%)

6359 (9.1%)

7323 (9.4%)

14,561 (6.8%)

14,608 (18.7%) 37,951 (17.8%)

0.08

0.00

0.07

0.01

0.01

Discharge disposition
Home

36,726 (65.1%) 4755 (52.8%) 49,184 (70.3%) 55,429 (71%)

146,094 (68.4%) 0.18

Home health

19,657 (34.9%) 4254 (47.2%) 20,813 (29.7%) 22,695 (29%)

67,419 (31.6%)

Values are presented as either mean (SD) or n (column %), unless otherwise indicated
POSH Post-hospital follow-up clinic visit, TPOSH Post-hospital follow-up telephone visit, nonPOSH visit not related to post-hospital follow-up
Wgtd Weighted maximum standardized differences across groups
a
Missingness < 0.1

–

–
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Table 3 Weighted models examining the effect of post-hospital follow-up provider visits completed within 7-days of discharge on
all cause 30-day inpatient and observation stay readmission stratified by age, service line, and readmission risk
All patients

Age: 65+

n = 213,513
Crude
HR (95%CI)

Age < 65

n = 102,011
Weighted
HR (95%CI)

Crude
HR (95%CI)

n = 111,502
Weighted
HR (95%CI)

Crude
HR (95%CI)

Weighted
HR (95%CI)

All Patients
POSH vs. no visit

1.34 (1.3, 1.38)

0.83 (0.77, 0.9)

1.17 (1.12, 1.22)

0.83 (0.76, 0.92)

1.38 (1.31, 1.46)

0.82 (0.71, 0.95)

TPOSH vs. no visit

1.85 (1.74, 1.95)

0.97 (0.9, 1.05)

1.51 (1.41, 1.62)

0.94 (0.86, 1.03)

2.10 (1.9, 2.32)

1.04 (0.92, 1.19)

nonPOSH vs. no visit

1.37 (1.33, 1.41)

1.05 (0.98, 1.13)

1.15 (1.11, 1.2)

1.08 (1.00, 1.18)

1.59 (1.53, 1.66)

0.98 (0.86, 1.12)

POSH vs. TPOSH

0.73 (0.68, 0.77)

0.85 (0.79, 0.93)

0.77 (0.72, 0.83)

0.89 (0.8, 0.98)

0.66 (0.59, 0.73)

0.79 (0.68, 0.91)

POSH vs. no visit

0.91 (0.88, 0.95)

0.79 (0.73, 0.86)

0.85 (0.81, 0.89)

0.81 (0.73, 0.89)

0.95 (0.89, 1.01)

0.75 (0.65, 0.88)

TPOSH vs. no visit

1.31 (1.23, 1.39)

0.95 (0.87, 1.02)

1.13 (1.05, 1.22)

0.93 (0.85, 1.02)

1.54 (1.38, 1.73)

0.98 (0.85, 1.13)

nonPOSH vs. no visit

1.14 (1.09, 1.18)

1.04 (0.96, 1.12)

1.11 (1.05, 1.17)

1.07 (0.98, 1.17)

1.19 (1.12, 1.26)

0.95 (0.82, 1.09)

POSH vs. TPOSH

0.7 (0.65, 0.74)

0.84 (0.77, 0.91)

0.75 (0.69, 0.80)

0.87 (0.78, 0.96)

0.61 (0.55, 0.69)

0.77 (0.65, 0.9)

Medicine, n = 112,668

LACE 11+ (High risk)
POSH vs. no visit

0.73 (0.69, 0.76)

0.77 (0.71, 0.85)

0.75 (0.71, 0.80)

0.79 (0.71, 0.88)

0.67 (0.62, 0.74)

0.72 (0.61, 0.86)

TPOSH vs. no visit

0.92 (0.86, 0.99)

0.91 (0.83, 0.99)

0.94 (0.87, 1.03)

0.92 (0.83, 1.02)

0.87 (0.76, 1.00)

0.87 (0.74, 1.03)

nonPOSH vs. no visit

0.99 (0.94, 1.04)

1.01 (0.93, 1.09)

1.04 (0.97, 1.11)

1.05 (0.96, 1.16)

0.89 (0.81, 0.97)

0.90 (0.77, 1.05)

POSH vs. TPOSH

0.79 (0.74, 0.85)

0.85 (0.77, 0.94)

0.80 (0.74, 0.87)

0.86 (0.77, 0.97)

0.78 (0.68, 0.89)

0.82 (0.69, 0.99)

LACE < 11 (Medium/low risk)
POSH vs. no visit

0.87 (0.82, 0.93)

0.84 (0.67, 1.05)

0.83 (0.76, 0.91)

0.86 (0.65, 1.15)

0.86 (0.78, 0.95)

0.79 (0.55, 1.13)

TPOSH vs. no visit

1.23 (1.06, 1.43)

1.14 (0.94, 1.39)

1.01 (0.83, 1.24)

1.02 (0.78, 1.33)

1.44 (1.15, 1.80)

1.32 (0.98, 1.78)

nonPOSH vs. no visit

1.21 (1.14, 1.29)

1.16 (0.96, 1.42)

1.16 (1.06, 1.27)

1.19 (0.92, 1.54)

1.27 (1.17, 1.39)

1.15 (0.85, 1.56)

POSH vs. TPOSH

0.71 (0.61, 0.82)

0.73 (0.58, 0.92)

0.82 (0.67, 1.01)

0.85 (0.63, 1.14)

0.59 (0.47, 0.75)

0.60 (0.42, 0.85)

All Surgical n = 100,845
POSH vs. no visit

1.35 (1.24, 1.46)

1.01 (0.8, 1.28)

1.21 (1.08, 1.35)

0.93 (0.69, 1.25)

1.34 (1.19, 1.51)

1.11 (0.76, 1.63)

TPOSH vs. no visit

1.68 (1.43, 1.96)

1.17 (0.94, 1.45)

1.48 (1.20, 1.83)

1.05 (0.79, 1.39)

1.68 (1.31, 2.15)

1.34 (0.94, 1.89)

nonPOSH vs. no visit

1.65 (1.57, 1.73)

1.07 (0.86, 1.34)

1.17 (1.08, 1.27)

1.01 (0.76, 1.36)

1.93 (1.82, 2.05)

1.18 (0.83, 1.67)

POSH vs. TPOSH

0.81 (0.68, 0.96)

0.87 (0.68, 1.10)

0.82 (0.65, 1.02)

0.89 (0.66, 1.20)

0.80 (0.61, 1.05)

0.83 (0.57, 1.21)

POSH vs. no visit

0.73 (0.64, 0.84)

0.77 (0.56, 1.07)

0.75 (0.63, 0.89)

0.80 (0.54, 1.16)

0.72 (0.58, 0.89)

0.72 (0.39, 1.32)

TPOSH vs. no visit

1.11 (0.88, 1.38)

1.1 (0.82, 1.47)

1.12 (0.84, 1.48)

1.05 (0.74, 1.49)

1.11 (0.76, 1.62)

1.20 (0.71, 2.03)

nonPOSH vs. no visit

0.95 (0.84, 1.06)

0.95 (0.7, 1.29)

0.93 (0.8, 1.09)

0.97 (0.67, 1.41)

0.95 (0.80, 1.13)

0.90 (0.52, 1.55)

POSH vs. TPOSH

0.66 (0.53, 0.84)

0.7 (0.51, 0.97)

0.67 (0.50, 0.90)

0.76 (0.51, 1.12)

0.64 (0.44, 0.95)

0.60 (0.33, 1.07)

LACE 11+ (High risk)

LACE < 11 (Medium/low risk)
POSH vs. no visit

1.21 (1.08, 1.36)

1.36 (0.96, 1.92)

1.21 (1.02, 1.43)

1.24 (0.76, 2.03)

1.14 (0.97, 1.34)

1.43 (0.87, 2.37)

TPOSH vs. no visit

1.3 (1.03, 1.65)

1.28 (0.91, 1.80)

1.22 (0.88, 1.70)

1.17 (0.72, 1.88)

1.27 (0.9, 1.80)

1.37 (0.84, 2.22)

nonPOSH vs. no visit

1.75 (1.66, 1.85)

1.30 (0.92, 1.82)

1.20 (1.09, 1.33)

1.17 (0.72, 1.92)

2.02 (1.9, 2.15)

1.42 (0.89, 2.27)

POSH vs. TPOSH

0.93 (0.72, 1.21)

1.06 (0.75, 1.49)

0.99 (0.69, 1.41)

1.07 (0.67, 1.70)

0.90 (0.62, 1.31)

1.05 (0.64, 1.73)

Values are presented as hazard ratio (HR) and 95% confidence intervals
POSH Post-hospital follow-up clinic visit, TPOSH Telephone post-hospital follow-up visit, nonPOSH Visit not related to post-hospital follow-up, LACE Length of stay;
Acuity of admission; Co-morbidities; Emergency visits in previous 6 months
Matching weights were used, based on multinomial propensity score models that included age, gender, race/ethnicity, being partnered, no-show history in the
last 12 months, receipt of medical financial assistance in the year prior to admission (a marker of social risk), frailty category, risk for readmission or early death
(LACE category), severity of hospitalization (LAPS2), service line (medicine vs. surgical), functional status (non-ambulatory, ambulatory with assistance, or
ambulatory) and fall risk (Schmid score of 3+) within 24 h of discharge; disposition (home vs. home health), and hospital site
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monitoring technologies for transitional care with
COVID-19 patients could serve as exemplars for optimizing transitional care approaches for other medical conditions in the future. Since the start of the pandemic
through December 2020, this health system conducted
87% of the transitional care management visits via telephone, 3% by video, and 10% in person, a complete flip
compared to the pre-pandemic era. While there are no
other published reports specifically on virtual care transition management practices, Eberly et al. [25] reported a
more balanced distribution of video (45%) and telephone
(55%) primary and specialty care visits from a large academic health system from March to May 2020. We expect
that video visits will increase over time with greater provider comfort and increased patient access to technology
[26] and also due to telehealth reimbursement for Medicare Advantage plans which took effect in January 1, 2020
but the long-term future of telehealth reimbursement in
fee-for-service Medicare remains to be seen after the end
of the public health emergency [23].
The finding that completion of any follow-up visit
whether with a provider or ancillary care staff within 7
days of hospital discharge was not associated with lower
readmission risk compared to no visit for surgical patients merit more detailed analyses by types of surgical
procedures (high vs. low risk, planned vs. unplanned) to
determine the optimal timing and appropriate type of
provider follow-up post hospitalization in order to
maximize value for health systems and payers [27]. In
contrast to medicine patients, nearly half of the surgical
patients did not have an outpatient follow-up visit within
a week of discharge. It is possible that because the vast
majority (87%) of these patients were considered as
lower risk for readmission (LACE scores < 11), follow-up
visits were rightly not prioritized by the discharging providers as our analyses showed that these visits were not
associated with any added benefit in terms of risk
reduction.
Strengths of this study included use of a large, diverse
contemporary cohort that was exposed to many changes
in the care transition management practices in recent
years, replication of findings from our previous, limited
analyses of an older study cohort, ability to balance relevant baseline covariates across comparison groups using
matching weights, and inclusion of both inpatient and observation stay readmissions as a primary outcome in anticipation of changes to how readmissions are counted in
the Center for Medicare and Medicaid Services Hospital
Readmission Reduction Program as of January 1, 2021.
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higher-level settings or in non-integrated care systems
where electronic records are not easily shared across
hospital and ambulatory care settings. The TPOSH volume was relatively small for several of the subgroups, especially for younger patients and those on the surgical
service, to obtain a reliable estimate of benefit or harm.
Since the care transition quality improvement efforts in
this health system did not distinguish across disease
states nor cause of the index admission except for medicine vs. surgical, we did not explore additional subgroup
analyses in this paper though this should be the focus of
future study. The matching weights were balanced on
measured covariates but the cohorts may differ in other
ways; omission of unmeasured confounders such as exposure to other care transition interventions and treatment adherence, as well selection bias, are other notable
limitations of this observational study design. Nonetheless, prior studies of heart failure and COPD for instance, have also reported an association between
completion of follow-up provider visits within 7 days
post-discharge and lower rates of 30-day readmission
[28, 29]. We did not account for the multiple comparisons in the subgroup analyses and thus some of the statistically significant findings may be spurious. However,
we were cautious with our interpretation of these results.
Finally, we were not able to assess the frequency of clinical escalations associated with the TPOSH visits.

Conclusions
We found that completion of either a clinic or telephone
provider follow-up visit within 7 days of hospital
discharge was associated with lower 30-day inpatient or
observation readmission compared to no visit only for
high risk medicine patients. The effects of the telephone
provider follow-up, though statistically significant, were
marginal at best during the pre-pandemic era. It remains
to be determined if greater use and comfort with virtual
visits by providers and patients as a result of the
pandemic might improve the effectiveness of these encounters. The dramatic transformation of care delivery
to virtual care in response to the COVID-19 pandemic
offers an unprecedented opportunity to further examine
the right mix of in-person clinic or home-based and remote care (telephone, video, and e-visits) for posthospital discharge follow-up across multiple relevant patient subgroups [30] to ensure equitable access to high
quality care transition services [25, 31, 32].
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